These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9257768)

  • 1. In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
    Barchiesi F; Falconi Di Francesco L; Scalise G
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1812-4. PubMed ID: 9257768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
    Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
    J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
    Perea S; Gonzalez G; Fothergill AW; Sutton DA; Rinaldi MG
    J Clin Microbiol; 2002 May; 40(5):1831-3. PubMed ID: 11980970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
    Hu Y; Hu Y; Lu Y; Huang S; Liu K; Han X; Mao Z; Wu Z; Zhou X
    Mycopathologia; 2017 Apr; 182(3-4):397-402. PubMed ID: 27659805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL; Edlind TD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
    Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
    J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
    Khodavandi A; Alizadeh F; Vanda NA; Karimi G; Chong PP
    Pharm Biol; 2014 Dec; 52(12):1505-9. PubMed ID: 24863276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced activity of antifungal drugs by lysozyme against Cryptococcus neoformans.
    Nakamura Y; Kano R; Watanabe S; Takahashi H; Hasegawa A
    Mycoses; 1998; 41(5-6):199-202. PubMed ID: 9715633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans.
    Sun L; Sun S; Cheng A; Wu X; Zhang Y; Lou H
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1586-91. PubMed ID: 19171796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain.
    Martinez-Suarez JV; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1512-6. PubMed ID: 7492095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
    Jain P; Akula I; Edlind T
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3195-201. PubMed ID: 14506030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synergistic antifungal activity of resveratrol with azoles against Candida albicans.
    Wang J; Zhang X; Gao L; Wang L; Song F; Zhang L; Wan Y
    Lett Appl Microbiol; 2021 Jun; 72(6):688-697. PubMed ID: 33550599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro study on the potential fungicidal effects of atorvastatin in combination with some azole drugs against multidrug resistant Candida albicans.
    Mahmoud DE; Faraag AHI; Abu El-Wafa WM
    World J Microbiol Biotechnol; 2021 Oct; 37(11):191. PubMed ID: 34632522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.
    Cavalheiro AS; Maboni G; de Azevedo MI; Argenta JS; Pereira DI; Spader TB; Alves SH; Santurio JM
    Antimicrob Agents Chemother; 2009 May; 53(5):2136-8. PubMed ID: 19289531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing susceptibility of Candida species to fluconazole and itraconazole using the microdilution assay.
    Seibold M; Werner E
    Mycoses; 1995; 38(11-12):443-8. PubMed ID: 8720193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
    Xia J; Qian F; Xu W; Zhang Z; Wei X
    Biofouling; 2017 Apr; 33(4):283-293. PubMed ID: 28317391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.